Annual Accounts Receivable:
$98.74M+$472.00K(+0.48%)Summary
- As of today, ACAD annual accounts receivable is $98.74 million, with the most recent change of +$472.00 thousand (+0.48%) on December 31, 2024.
- During the last 3 years, ACAD annual accounts receivable has risen by +$34.37 million (+53.40%).
- ACAD annual accounts receivable is now at all-time high.
Performance
ACAD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$107.50M+$1.76M(+1.67%)Summary
- As of today, ACAD quarterly accounts receivable is $107.50 million, with the most recent change of +$1.76 million (+1.67%) on June 30, 2025.
- Over the past year, ACAD quarterly accounts receivable has increased by +$3.81 million (+3.67%).
- ACAD quarterly accounts receivable is now at all-time high.
Performance
ACAD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ACAD Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +0.5% | +3.7% |
| 3Y3 Years | +53.4% | +58.2% |
| 5Y5 Years | +175.9% | +145.5% |
ACAD Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +58.8% | at high | +92.9% |
| 5Y | 5-Year | at high | +175.9% | at high | +132.0% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
ACAD Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $107.50M(+1.7%) |
| Mar 2025 | - | $105.74M(+7.1%) |
| Dec 2024 | $98.74M(+0.5%) | $98.74M(+0.5%) |
| Sep 2024 | - | $98.21M(-5.3%) |
| Jun 2024 | - | $103.70M(+9.5%) |
| Mar 2024 | - | $94.70M(-3.6%) |
| Dec 2023 | $98.27M(+58.0%) | $98.27M(+5.9%) |
| Sep 2023 | - | $92.80M(+13.4%) |
| Jun 2023 | - | $81.85M(+24.2%) |
| Mar 2023 | - | $65.92M(+6.0%) |
| Dec 2022 | $62.20M(-3.4%) | $62.20M(+11.6%) |
| Sep 2022 | - | $55.73M(-18.0%) |
| Jun 2022 | - | $67.95M(+8.4%) |
| Mar 2022 | - | $62.71M(-2.6%) |
| Dec 2021 | $64.37M(+33.4%) | $64.37M(+6.0%) |
| Sep 2021 | - | $60.70M(+18.2%) |
| Jun 2021 | - | $51.37M(-9.6%) |
| Mar 2021 | - | $56.83M(+17.8%) |
| Dec 2020 | $48.25M | $48.25M(+4.1%) |
| Sep 2020 | - | $46.34M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $43.78M(+5.2%) |
| Mar 2020 | - | $41.64M(+16.4%) |
| Dec 2019 | $35.78M(+37.1%) | $35.78M(+16.2%) |
| Sep 2019 | - | $30.80M(-3.1%) |
| Jun 2019 | - | $31.78M(+6.1%) |
| Mar 2019 | - | $29.96M(+14.8%) |
| Dec 2018 | $26.09M(+50.4%) | $26.09M(+30.7%) |
| Sep 2018 | - | $19.96M(-22.3%) |
| Jun 2018 | - | $25.70M(+14.5%) |
| Mar 2018 | - | $22.45M(+29.4%) |
| Dec 2017 | $17.34M(+193.8%) | $17.34M(+22.0%) |
| Sep 2017 | - | $14.22M(+22.7%) |
| Jun 2017 | - | $11.59M(+51.4%) |
| Mar 2017 | - | $7.66M(+29.8%) |
| Dec 2016 | $5.90M(>+9900.0%) | $5.90M(+53.8%) |
| Sep 2016 | - | $3.84M(+1210.2%) |
| Jun 2016 | - | $293.00K(-84.9%) |
| Sep 2010 | - | $1.93M(-34.0%) |
| Jun 2010 | - | $2.93M |
| Dec 2009 | $0.00(0.0%) | - |
| Dec 2008 | $0.00 | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual accounts receivable year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly accounts receivable year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual accounts receivable?
The current annual accounts receivable of ACAD is $98.74M
What is the all-time high annual accounts receivable for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual accounts receivable is $98.74M
What is ACADIA Pharmaceuticals Inc. annual accounts receivable year-on-year change?
Over the past year, ACAD annual accounts receivable has changed by +$472.00K (+0.48%)
What is ACADIA Pharmaceuticals Inc. quarterly accounts receivable?
The current quarterly accounts receivable of ACAD is $107.50M
What is the all-time high quarterly accounts receivable for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly accounts receivable is $107.50M
What is ACADIA Pharmaceuticals Inc. quarterly accounts receivable year-on-year change?
Over the past year, ACAD quarterly accounts receivable has changed by +$3.81M (+3.67%)